Treating Multiple Sclerosis From Many Angles

Lemtrada Stroke Lawsuit News

Stem Cell Therapy offers new hope for advanced RRMS patients

Friday, June 21, 2019 - The National Multiple Sclerosis Society is highly optimistic when it comes using stem cell therapy to treat MS and think the therapy can both slow down the progress of the disease and also repair cells damaged by the disorder. The society thinks that it is a good idea for those with advanced MS to consider stem cell treatments.

Multiple sclerosis is often confused with muscular dystrophy, a completely different disease. Multiple sclerosis is prevalent and transcends economic and racial barriers throughout society. Virtually everyone knows at least one person who has multiple sclerosis. MS is different from other diseases that are more or less hidden in that the symptoms of the disease can be outwardly obvious, such as difficulty walking or being wheelchair-bound. Although some people exhibit these and other outward symptoms of the disease most people are unaware that a person has the disorder. People may look normal on the outside but MS patients struggle with the symptoms. People with MS are encouraged to take good care of their health, exercise regularly, and eat a healthy diet to limit the severity of the disease. Alcohol abuse, obesity, and smoking will make the symptoms of MS much worse. Being otherwise healthy and leading a healthy lifestyle will help an individual cope with MS. Drug therapies that have been tested in studies and are known to work can provide additional benefits to lessen the symptoms of MS. Researchers continue to struggle with pinpointing what triggers MS. Genetic history plays a role but in and of itself is not thought to be the only determinate of who does or does not contract MS. It is thought that MS develops in genetically susceptible individuals that are exposed to a triggering event such as exposure to certain viruses at a young age. Lemtrada lawsuit attorneys are helping families in the United States and believe persons who have suffered from Lemtrada stroke may be eligible for significant compensation for the pain, suffering, medical expenses, and damage related to this dangerous drug.

Of all of the studies in treating MS, stem cell therapy stands out as offering MS sufferers the greatest hope. According to, "doctors use a type of stem cell treatment called hematopoietic stem cell transplantation (HSCT) to treat RRMS." According to the National MS Society, hematopoietic cells are adult stem cells that are found in bone marrow and blood that produce all of the cells that make up the blood and the immune system. These cells are harvested and treated with chemotherapy to remove the MS cells and then replaced intravenously.

It should be noted that MS stem cell therapy is in its earliest stages and is not approved by the FDA. "HSCT doesn't work for everyone with MS. Most people who get it are taking part in research studies called clinical trials that test if a treatment or medication is safe and effective." Stem cell therapy has produced encouraging results in almost 70% of those given the treatment. These patients "didn't have a relapse in RRMS symptoms or new brain lesions, which are caused by MS, 5 years after treatment." Of all of the side effects of stem cell therapy, infection is high on the list as a patient will have a weakened immune system.

More Recent Lemtrada Stroke Lawsuit News:

No-Cost, No-Obligation Lemtrada Lawsuit Case Review If You or a Loved One Suffered from Lemtrada Stroke Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.